NEW YORK, March 7, 2019 – Levi & Korsinsky, LLP announces the commencement of a class action on behalf of all persons or entities who purchased or otherwise acquired securities of Tyme Technologies, Inc. (“Tyme”) (NASDAQCM: TYME) between March 14, 2018 and January 18, 2019. You are hereby notified that the TYME class action lawsuit has been commenced in the United States District Court for the Southern District of New York. To get more information about the Tyme lawsuit go to: https://www.zlk.com/pslra-1/tyme-technologies-inc-loss-form or contact Joseph E. Levi, Esq. either via email at firstname.lastname@example.org or by telephone at (212) 363-7500, toll-free: (877) 363-5972. There is no cost or obligation to you.
The TYME lawsuit alleges that throughout the class period Defendants issued materially false and/or misleading statements and/or failed to disclose that: (i) Tyme had not adequately designed the Phase II Study to present reliable results on the efficacy of SM-88 on pancreatic cancer; (ii) Tyme had failed to include an appropriate control group in its open-label Phase II clinical trial for SM-88; (iii) the omission of an appropriate control group distorted the reliability of data showing the efficacy of SM-88 in the Phase II Study; and (iv) as a result, Tyme’s public statements were materially false and misleading at all relevant times.
If you suffered a loss in Tyme you have until March 29, 2019 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.
Levi & Korsinsky is a national firm with offices in New York, California, Connecticut, and Washington D.C. The firm’s attorneys have extensive expertise and experience representing investors in securities litigation, and have recovered hundreds of millions of dollars for aggrieved shareholders. Attorney advertising. Prior results do not guarantee similar outcomes.
Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
55 Broadway, 10th Floor
New York, NY 10006
Tel: (212) 363-7500
Toll Free: (877) 363-5972
Fax: (212) 363-7171